Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-25-007997
Filing Date
2025-01-29
Accepted
2025-01-29 19:29:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 12110
2 ANNEX A ea022913001ex99-1_cardenal.htm EX-99.1 6550
3 JOINT FILING AGREEMENT ea022913001ex-2_cardenal.htm EX-2 5780
  Complete submission text file 0001213900-25-007997.txt   25885
Mailing Address 89 MELROSE DRIVE MISSION VIEJO CA 92692
Business Address
Pham Quang X (Filed by) CIK: 0001405290 (see all company filings)

Type: SCHEDULE 13D

Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Subject) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94027 | Film No.: 25570680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)